DNA methylation in lung cancer patients: Opening a "window of life" under precision medicine
出版年份 2021 全文链接
标题
DNA methylation in lung cancer patients: Opening a "window of life" under precision medicine
作者
关键词
DNA methylation, Lung cancer, Liquid biopsy, Biomarker, Treatment, Prognosis
出版物
BIOMEDICINE & PHARMACOTHERAPY
Volume 144, Issue -, Pages 112202
出版商
Elsevier BV
发表日期
2021-10-14
DOI
10.1016/j.biopha.2021.112202
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- DNA methylation of PTGER4 in peripheral blood plasma helps to distinguish between lung cancer, benign pulmonary nodules and chronic obstructive pulmonary disease patients
- (2021) Lea M. Schotten et al. EUROPEAN JOURNAL OF CANCER
- P46.06 Cell-Free DNA (cfDNA) Methylation Assay Allows for Early Detection and Identification of Lung Cancer
- (2021) K. Kruusmaa et al. Journal of Thoracic Oncology
- Comprehensive cell type decomposition of circulating cell-free DNA with CelFiE
- (2021) Christa Caggiano et al. Nature Communications
- The performance of the SHOX2/PTGER4 methylation assay is influenced by cancer stage, age, type and differentiation
- (2020) Zheyuan Xu et al. Biomarkers in Medicine
- FAM83A Is a Prognosis Signature and Potential Oncogene of Lung Adenocarcinoma
- (2020) Jing Yu et al. DNA AND CELL BIOLOGY
- Integrating genomic features for non-invasive early lung cancer detection
- (2020) Jacob J. Chabon et al. NATURE
- Non-invasive early detection of cancer four years before conventional diagnosis using a blood test
- (2020) Xingdong Chen et al. Nature Communications
- Clinical and prognostic pan-cancer analysis of m6A RNA methylation regulators in four types of endocrine system tumors
- (2020) Kai Li et al. Aging-US
- Cancer statistics, 2019
- (2019) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Guide Positioning Sequencing identifies aberrant DNA methylation patterns that alter cell identity and tumor-immune surveillance networks
- (2019) Jin Li et al. GENOME RESEARCH
- Hypermethylation of the G protein‐coupled receptor kinase 6 (GRK6) promoter inhibits binding of C/EBPα, and GRK6 knockdown promotes cell migration and invasion in lung adenocarcinoma cells
- (2019) Sumei Yao et al. FEBS Open Bio
- Dependency of the Cancer-Specific Transcriptional Regulation Circuitry on the Promoter DNA Methylome
- (2019) Yu Liu et al. Cell Reports
- Modification of histone proteins by serotonin in the nucleus
- (2019) Marlene Cervantes et al. NATURE
- Genome-Wide Plasma Cell-Free DNA Methylation Profiling Identifies Potential Biomarkers for Lung Cancer
- (2019) Wei Xu et al. DISEASE MARKERS
- Epigenetic alterations are associated with tumor mutation burden in non-small cell lung cancer
- (2019) Liangliang Cai et al. Journal for ImmunoTherapy of Cancer
- Subtyping Lung Cancer Using DNA Methylation in Liquid Biopsies
- (2019) Nunes et al. Journal of Clinical Medicine
- 1479OIntegrated genomic and DNA methylation analyses of non-small cell lung cancer patients with brain metastases
- (2019) Y Fan et al. ANNALS OF ONCOLOGY
- Targeted methylation sequencing of plasma cell-free DNA for cancer detection and classification
- (2018) L Liu et al. ANNALS OF ONCOLOGY
- Epigenome-based cancer risk prediction: rationale, opportunities and challenges
- (2018) Martin Widschwendter et al. Nature Reviews Clinical Oncology
- Heterogeneity in Lung Cancer
- (2018) Vitor Manuel Leitão de Sousa et al. PATHOBIOLOGY
- Methylation of L1RE1, RARB, and RASSF1 function as possible biomarkers for the differential diagnosis of lung cancer
- (2018) R. F. H. Walter et al. PLoS One
- Principles of DNA methylation and their implications for biology and medicine
- (2018) Yuval Dor et al. LANCET
- Blood-based tumor mutational burden as a predictor of clinical benefit in non-small-cell lung cancer patients treated with atezolizumab
- (2018) David R. Gandara et al. NATURE MEDICINE
- Lung Cancers: Molecular Characterization, Clonal Heterogeneity and Evolution, and Cancer Stem Cells
- (2018) Ugo Testa et al. Cancers
- Early Noninvasive Detection of Response to Targeted Therapy in Non-Small Cell Lung Cancer
- (2018) Jillian Phallen et al. CANCER RESEARCH
- Sensitive tumour detection and classification using plasma cell-free DNA methylomes
- (2018) Shu Yi Shen et al. NATURE
- GADD45A binds R-loops and recruits TET1 to CpG island promoters
- (2018) Khelifa Arab et al. NATURE GENETICS
- DNA methylation analysis of selected genes for the detection of early-stage lung cancer using circulating cell-free DNA
- (2018) Zhiping Yang et al. Advances in Clinical and Experimental Medicine
- Analysis of DNA Methylation Status in Bodily Fluids for Early Detection of Cancer
- (2017) Keigo Yokoi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Validation of the SHOX2 / PTGER4 DNA Methylation Marker Panel for Plasma-Based Discrimination between Patients with Malignant and Nonmalignant Lung Disease
- (2017) Gunter Weiss et al. Journal of Thoracic Oncology
- O 6 -Methylguanine-DNA methyltransferase (MGMT): A drugable target in lung cancer?
- (2017) Birgitta I. Hiddinga et al. LUNG CANCER
- Identification of methylation haplotype blocks aids in deconvolution of heterogeneous tissue samples and tumor tissue-of-origin mapping from plasma DNA
- (2017) Shicheng Guo et al. NATURE GENETICS
- Tumor Mutational Burden and Response Rate to PD-1 Inhibition
- (2017) Mark Yarchoan et al. NEW ENGLAND JOURNAL OF MEDICINE
- DNA methylation markers for diagnosis and prognosis of common cancers
- (2017) Xiaoke Hao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The cancer epigenome: Concepts, challenges, and therapeutic opportunities
- (2017) Mark A. Dawson SCIENCE
- Early Detection of Molecular Residual Disease in Localized Lung Cancer by Circulating Tumor DNA Profiling
- (2017) Aadel A. Chaudhuri et al. Cancer Discovery
- Establishment of a Strong Link Between Smoking and Cancer Pathogenesis through DNA Methylation Analysis
- (2017) Yunlong Ma et al. Scientific Reports
- DNA Methylation Analysis of the SHOX2 and RASSF1A Panel in Bronchoalveolar Lavage Fluid for Lung Cancer Diagnosis
- (2017) Chenzi Zhang et al. Journal of Cancer
- Lung Cancer Screening With Low-Dose Computed Tomography in the United States—2010 to 2015
- (2017) Ahmedin Jemal et al. JAMA Oncology
- Promoter methylation of Wnt/β-Catenin signal inhibitor TMEM88 is associated with unfavorable prognosis of non-small cell lung cancer
- (2017) Ma Rongna et al. Cancer Biology & Medicine
- A panel of promoter methylation markers for invasive and noninvasive early detection of NSCLC using a quantum dots-based FRET approach
- (2016) Yunfei Ma et al. BIOSENSORS & BIOELECTRONICS
- Prognostic significance of CpG island methylator phenotype in surgically resected small cell lung carcinoma
- (2016) Yuichi Saito et al. CANCER SCIENCE
- Early Detection of Lung Cancer Using DNA Promoter Hypermethylation in Plasma and Sputum
- (2016) Alicia Hulbert et al. CLINICAL CANCER RESEARCH
- DNA methylation changes measured in pre-diagnostic peripheral blood samples are associated with smoking and lung cancer risk
- (2016) Laura Baglietto et al. INTERNATIONAL JOURNAL OF CANCER
- DNA hypermethylation analysis in sputum of asymptomatic subjects at risk for lung cancer participating in the NELSON trial: argument for maximum screening interval of 2 years
- (2016) A Jasmijn Hubers et al. JOURNAL OF CLINICAL PATHOLOGY
- Small-cell lung cancer in never-smokers: A case series
- (2016) Ana Tavares e Castro et al. LUNG CANCER
- Hypomethylation of human-specific family of LINE-1 retrotransposons in circulating DNA of lung cancer patients
- (2016) Ildar V. Gainetdinov et al. LUNG CANCER
- Genome-wide DNA methylation patterns in CD4+ T cells from Chinese Han patients with rheumatoid arthritis
- (2016) Shicheng Guo et al. Modern Rheumatology
- Epigenetic Modulators and the New Immunotherapies
- (2016) Anthony E. Dear NEW ENGLAND JOURNAL OF MEDICINE
- Epigenetic Determinants of Cancer
- (2016) Stephen B. Baylin et al. Cold Spring Harbor Perspectives in Biology
- Tobacco smoking and methylation of genes related to lung cancer development
- (2016) Xu Gao et al. Oncotarget
- Base-Position Error Rate Analysis of Next-Generation Sequencing Applied to Circulating Tumor DNA in Non-Small Cell Lung Cancer: A Prospective Study
- (2016) Nicolas Pécuchet et al. PLOS MEDICINE
- Smoking-associated DNA methylation markers predict lung cancer incidence
- (2016) Yan Zhang et al. Clinical Epigenetics
- Distinguishing Lung Adenocarcinoma from Lung Squamous Cell Carcinoma by Two Hypomethylated and Three Hypermethylated Genes: A Meta-Analysis
- (2016) Tao Huang et al. PLoS One
- Plasma DNA tissue mapping by genome-wide methylation sequencing for noninvasive prenatal, cancer, and transplantation assessments
- (2015) Kun Sun et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Accessing Genetic Information with Liquid Biopsies
- (2015) Xuyu Cai et al. TRENDS IN GENETICS
- Circulating Tumor DNA as a Liquid Biopsy for Cancer
- (2014) E. Heitzer et al. CLINICAL CHEMISTRY
- Identification of HERC5 and its potential role in NSCLC progression
- (2014) Michaela Wrage et al. INTERNATIONAL JOURNAL OF CANCER
- Targeted p16Ink4a epimutation causes tumorigenesis and reduces survival in mice
- (2014) Da-Hai Yu et al. JOURNAL OF CLINICAL INVESTIGATION
- Cancer biomarkers: Written in blood
- (2014) Ed Yong NATURE
- Cost-Effectiveness of CT Screening in the National Lung Screening Trial
- (2014) William C. Black et al. NEW ENGLAND JOURNAL OF MEDICINE
- Associations Between RASSF1A Promoter Methylation and NSCLC: A Meta-analysis of Published Data
- (2013) Wen-Jian Liu et al. Asian Pacific Journal of Cancer Prevention
- Potentialities of aberrantly methylated circulating DNA for diagnostics and post-treatment follow-up of lung cancer patients
- (2013) Anastasia A. Ponomaryova et al. LUNG CANCER
- Mutational heterogeneity in cancer and the search for new cancer-associated genes
- (2013) Michael S. Lawrence et al. NATURE
- Epigenetic Inactivation of Heparan Sulfate (Glucosamine) 3-O-Sulfotransferase 2 in Lung Cancer and Its Role in Tumorigenesis
- (2013) Jung-Ah Hwang et al. PLoS One
- Methylation status of O6-methylguanine-DNA-methyl transferase promoter region in non-small-cell lung cancer patients with brain metastasis
- (2012) Kenji Hashimoto et al. Clinical & Translational Oncology
- R-Loop Formation Is a Distinctive Characteristic of Unmethylated Human CpG Island Promoters
- (2012) Paul A. Ginno et al. MOLECULAR CELL
- The Role of Methylation in the Intrinsic Dynamics of B- and Z-DNA
- (2012) Nuri A. Temiz et al. PLoS One
- Loss of expression of the differentially expressed in adenocarcinoma of the lung (DAL-1) protein is associated with metastasis of non-small cell lung carcinoma cells
- (2012) Yajie Zhang et al. TUMOR BIOLOGY
- RARβ2 gene methylation level in the circulating DNA from blood of patients with lung cancer
- (2011) Anastasia A. Ponomaryova et al. EUROPEAN JOURNAL OF CANCER PREVENTION
- SHOX2 DNA Methylation Is a Biomarker for the Diagnosis of Lung Cancer in Plasma
- (2011) Christoph Kneip et al. Journal of Thoracic Oncology
- SHOX2 DNA Methylation is a Biomarker for the diagnosis of lung cancer based on bronchial aspirates
- (2010) Bernd Schmidt et al. BMC CANCER
- The EPHB6 Receptor Tyrosine Kinase Is a Metastasis Suppressor That Is Frequently Silenced by Promoter DNA Hypermethylation in Non-Small Cell Lung Cancer
- (2010) J. Yu et al. CLINICAL CANCER RESEARCH
- IGFBP-3 hypermethylation-derived deficiency mediates cisplatin resistance in non-small-cell lung cancer
- (2009) I Ibanez de Caceres et al. ONCOGENE
- Epigenetics in Cancer
- (2008) Manel Esteller NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now